DSFI Stock Financial Analysis - DSM-Firmenich AG (WBAG) Stock

Overview

DSM-Firmenich AG, based in Switzerland, represents a prominent global entity in the nutrition, health, and bioscience industries, formed from the merger of Royal DSM and Firmenich. As a pivotal player in its domain, the company engages in the development and production of health-centric and sustainable biotechnological solutions. Key projects reflect its dedication to innovation in nutrition and wellness, with DSM-Fimernich continually venturing into areas like personalized nutrition, environmentally friendly agricultural practices, and cutting-edge food technology. The company's strategic initiatives aim to address pressing global challenges such as food security and sustainability, positioning DSM-Firmenich at the forefront of advancing health and ecological well-being through science.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for DSM-Firmenich AG as of 30 June 2025 is 13,011.00 MM.
The operating income for DSM-Firmenich AG as of 30 June 2025 is 1,138.00 MM.
The net income for DSM-Firmenich AG as of 30 June 2025 is 718.00 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	13,011.00	1,138.00	718.00
2025-03-31	12,905.00	823.50	484.00
2024-12-31	12,799.00	509.00	250.00
2024-09-30	12,627.00	207.00	31.00
2024-06-30	12,455.00	-32.00	-188.00
2024-03-31	11,541.00	-296.00	974.50
2023-12-31	10,627.00	-560.00	2,137.00
2023-09-30	9,686.00	-322.00	2,877.00
2023-06-30	8,745.00	-117.00	3,617.00
2023-03-31	8,567.50	267.50	2,658.50
2022-12-31	8,390.00	652.00	1,700.00
2022-09-30	9,581.50	960.50	1,409.00
2022-06-30	7,867.00	714.00	1,118.00
2022-03-31	7,568.00	712.00	1,397.00
2021-12-31	7,269.00	710.00	1,676.00
2021-09-30	7,955.00	564.50	1,398.00
2021-06-30	7,558.00	594.00	1,246.00
2021-03-31	7,571.50	597.00	843.00
2020-12-31	8,106.00	672.00	506.00
2020-09-30	7,960.00	750.00	573.00
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	0.94	0.94
2024-09-30	0.12	0.11
2024-06-30	-0.71	-0.71
2024-03-31	3.90	3.89
2023-12-31	9.14	9.13
2023-09-30	13.66	13.62
2023-06-30	19.30	19.24
2023-03-31	14.74	14.69
2022-12-31	9.80	9.77
2022-09-30	8.13	8.10
2022-06-30	6.46	6.44
2022-03-31	8.06	8.04
2021-12-31	9.68	9.63
2021-09-30	8.07	7.99
2021-06-30	7.19	7.14
2021-03-31	4.87	4.83
2020-12-31	2.91	2.89
2020-09-30	3.28	3.26
2020-06-30	3.58	3.55
2020-03-31	4.14	4.11

Cash Flow: Operations, Investing, Financing

The cash from operating activities for DSM-Firmenich AG as of 30 June 2025 is 1,590.00 MM.
The cash from investing activities for DSM-Firmenich AG as of 30 June 2025 is 1,131.00 MM.
The cash from financing activities for DSM-Firmenich AG as of 30 June 2025 is -796.00 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	1,590.00	1,131.00	-796.00
2025-03-31	1,684.00	439.50	-1,065.00
2024-12-31	1,778.00	-252.00	-1,334.00
2024-09-30	1,615.00	-413.00	-2,083.00
2024-06-30	1,452.00	-573.00	-2,833.00
2024-03-31	1,358.50	-649.50	-1,826.50
2023-12-31	1,265.00	-726.00	-820.00
2023-09-30	1,112.00	100.00	-282.50
2023-06-30	959.00	954.00	227.00
2023-03-31	962.00	915.00	-209.00
2022-12-31	965.00	876.00	-645.00
2022-09-30	1,056.00	-261.00	-652.50
2022-06-30	1,147.00	-1,427.00	-631.00
2022-03-31	1,287.00	-609.50	-807.50
2021-12-31	1,427.00	208.00	-984.00
2021-09-30	1,507.00	-397.50	-1,207.00
2021-06-30	1,489.00	486.00	-1,618.00
2021-03-31	1,496.50	-1,319.50	-294.00
2020-12-31	1,494.00	-1,482.00	83.00
2020-09-30	1,434.00	-647.00	12.00
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for DSM-Firmenich AG as of 30 June 2025 is 96.19.
The p/book for DSM-Firmenich AG as of 30 June 2025 is 1.06.
The p/tbv for DSM-Firmenich AG as of 30 June 2025 is 5.42.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30	96.19	1.06	5.42
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30	5.03	0.79	3.93
2023-06-30
2023-03-31
2022-12-31	11.14	1.45	2.80
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for DSM-Firmenich AG as of 30 June 2025 is 0.02.
The ebit (3y)/ev for DSM-Firmenich AG as of 30 June 2025 is 0.00.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	0.02	0.00
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30	-0.01	0.03
2023-06-30
2023-03-31
2022-12-31	0.06	0.06
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for DSM-Firmenich AG as of 30 June 2025 is 0.01.
The roe for DSM-Firmenich AG as of 30 June 2025 is 0.01.
The roic for DSM-Firmenich AG as of 30 June 2025 is 0.01.
The croic for DSM-Firmenich AG as of 30 June 2025 is 0.01.
The ocroic for DSM-Firmenich AG as of 30 June 2025 is 0.06.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.01	0.01	0.01	0.01	0.06
2025-03-31	0.01	0.02	0.01	0.01	0.06
2024-12-31	-0.01	0.01	-0.01	-0.07	0.05
2024-09-30	-0.01	0.00	-0.01	-0.07	0.05
2024-06-30	0.06	0.04	0.08	-0.01	0.04
2024-03-31	0.12	0.20	0.08	-0.01	0.04
2023-12-31	0.21	0.33	0.10	0.03	0.04
2023-09-30	0.21	0.37	0.13	0.07	0.03
2023-06-30	0.21	0.37	0.13	0.07	0.03
2023-03-31	0.16	0.27	0.09	0.06	0.03
2022-12-31	0.09	0.15	0.10	0.01	0.07
2022-09-30	0.09	0.15	0.10	0.01	0.07
2022-06-30	0.07	0.13	0.09	-0.06	0.09
2022-03-31	0.09	0.16	0.11	-0.01	0.10
2021-12-31	0.12	0.22	0.13	0.05	0.11
2021-09-30	0.10	0.19	0.11	-0.01	0.12
2021-06-30	0.08	0.17	0.10	0.03	0.12
2021-03-31	0.06	0.11	0.07	-0.01	0.12
2020-12-31	0.04	0.06	0.04	0.01	0.13
2020-09-30	0.04	0.07	0.05	0.07	0.13
2020-06-30	0.05	0.08	0.05	0.01	0.13
2020-03-31	0.05	0.09	0.07	0.03	0.13

Gross Margins

The gross margin for DSM-Firmenich AG as of 30 June 2025 is 0.33.
The net margin for DSM-Firmenich AG as of 30 June 2025 is 0.02.
The operating margin for DSM-Firmenich AG as of 30 June 2025 is 0.04.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.33	0.02	0.04
2025-03-31	0.33	0.02	0.04
2024-12-31	0.27	-0.02	-0.00
2024-09-30	0.27	-0.02	-0.00
2024-06-30	0.25	0.20	-0.05
2024-03-31	0.25	0.20	-0.05
2023-12-31	0.31	0.30	-0.03
2023-09-30	0.31	0.41	-0.01
2023-06-30	0.31	0.41	-0.01
2023-03-31	0.31	0.31	0.03
2022-12-31	0.48	0.15	0.10
2022-09-30	0.48	0.15	0.10
2022-06-30	0.34	0.11	0.10
2022-03-31	0.34	0.15	0.11
2021-12-31	0.34	0.18	0.12
2021-09-30	0.40	0.16	0.09
2021-06-30	0.38	0.15	0.09
2021-03-31	0.34	0.10	0.09
2020-12-31	0.34	0.06	0.17
2020-09-30	0.34	0.06	0.09
2020-06-30	0.34	0.07	0.09
2020-03-31	0.34	0.08	0.10

US:DSMFF
GB:0AC9	€ 82,07
GB:DSFIRA
DE:ZX6
NL:DSFIR	€ 82,02
MX:DSFIR N